Literature DB >> 4030104

Correlation of plasmid type and disease caused by Coxiella burnetii.

J E Samuel, M E Frazier, L P Mallavia.   

Abstract

The obligate intracellular bacterium Coxiella burnetii is the etiological agent of acute Q-fever and chronic endocarditis in humans and of several zoonotic infections. The DNA from a variety of these disease isolates was compared for homology to the plasmid QpH1, found in the Nine Mile strain. Three patterns of homology were found in these isolates, i.e., one pattern identical to that of QpH1, one common to several endocarditis isolates and goat abortion isolates, and one common to the remaining group of endocarditis isolates. Plasmid DNA from the endocarditis-abortion isolate group, designated QpRS, was mapped by restriction enzyme analysis and compared with QpH1. These data show that QpRS was 2 to 3 kilobase pairs larger, contained DNA not found in QpH1, but was not generated from QpH1 by a single insertional event. Isolation of plasmid DNA from the second endocarditis group of isolates was not successful and may indicate that the plasmid has integrated into the chromosome. This analysis provides the first clear evidence that differences exist between C. burnetii isolates which cause various diseases, indicating that different C. burnetii strains may have unique virulence characteristics.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4030104      PMCID: PMC261272          DOI: 10.1128/iai.49.3.775-779.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  Q FEVER STUDIES IN MONTANA. DETECTION OF ASYMPTOMATIC INFECTION AMONG RESIDENTS OF INFECTED DAIRY PREMISES.

Authors:  L LUOTO; M L CASEY; E G PICKENS
Journal:  Am J Epidemiol       Date:  1965-05       Impact factor: 4.897

2.  Phase variation of the Nine Mile and other strains of Rickettsia burneti.

Authors:  M G STOKER; P FISET
Journal:  Can J Microbiol       Date:  1956-05       Impact factor: 2.419

3.  In vitro evaluation of immunity to Coxiella burnetii.

Authors:  D J Hinrichs; T R Jerrells
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

4.  Active transport of proline by Coxiella burnetii.

Authors:  L Hendrix; L P Mallavia
Journal:  J Gen Microbiol       Date:  1984-11

5.  Isolation and characterization of a plasmid from phase I Coxiella burnetii.

Authors:  J E Samuel; M E Frazier; M L Kahn; L S Thomashow; L P Mallavia
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

6.  Q fever endocarditis in the United States.

Authors:  R C Kimbrough; R A Ormsbee; M Peacock; W R Rogers; R W Bennetts; J Raaf; A Krause; C Gardner
Journal:  Ann Intern Med       Date:  1979-09       Impact factor: 25.391

7.  Lesions in guinea pigs infected with Coxiella burnetii strain M-44.

Authors:  J W Johnson; C G McLeod; J L Stookey; G A Higbee; C E Pedersen
Journal:  J Infect Dis       Date:  1977-06       Impact factor: 5.226

8.  Q fever endocarditis.

Authors:  M J Tobin; N Cahill; G Gearty; B Maurer; S Blake; K Daly; R Hone
Journal:  Am J Med       Date:  1982-03       Impact factor: 4.965

9.  Antibody-dependent cellular cytotoxicity of Coxiella burnetii-infected J774 macrophage target cells.

Authors:  F T Koster; T L Kirkpatrick; J D Rowatt; O G Baca
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

10.  Serological evaluation of O fever in humans: enhanced phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis.

Authors:  M G Peacock; R N Philip; J C Williams; R S Faulkner
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

View more
  85 in total

1.  Coxiella burnetii exhibits morphological change and delays phagolysosomal fusion after internalization by J774A.1 cells.

Authors:  D Howe; L P Mallavia
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Differential expression of translational elements by life cycle variants of Coxiella burnetii.

Authors:  R Seshadri; L R Hendrix; J E Samuel
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Use of monoclonal antibodies to lipopolysaccharide for antigenic analysis of Coxiella burnetii.

Authors:  Akitoyo Hotta; Midori Kawamura; Ho To; Masako Andoh; Tsuyoshi Yamaguchi; Hideto Fukushi; Ken-Ichi Amano; Katsuya Hirai
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  Cloning and porin activity of the major outer membrane protein P1 from Coxiella burnetii.

Authors:  Sunita Varghees; Kati Kiss; Giovanni Frans; Orit Braha; James E Samuel
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  Detection of Coxiella burnetti by DNA amplification using polymerase chain reaction.

Authors:  A Stein; D Raoult
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

6.  Phagolysosomes of Coxiella burnetii-infected cell lines maintain an acidic pH during persistent infection.

Authors:  M Maurin; A M Benoliel; P Bongrand; D Raoult
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

7.  The Coxiella burnetii cryptic plasmid is enriched in genes encoding type IV secretion system substrates.

Authors:  Daniel E Voth; Paul A Beare; Dale Howe; Uma M Sharma; Georgios Samoilis; Diane C Cockrell; Anders Omsland; Robert A Heinzen
Journal:  J Bacteriol       Date:  2011-01-07       Impact factor: 3.490

8.  Transposon insertion reveals pRM, a plasmid of Rickettsia monacensis.

Authors:  Gerald D Baldridge; Nicole Y Burkhardt; Roderick F Felsheim; Timothy J Kurtti; Ulrike G Munderloh
Journal:  Appl Environ Microbiol       Date:  2007-06-15       Impact factor: 4.792

9.  Acute Q fever in Portugal. Epidemiological and clinical features of 32 hospitalized patients.

Authors:  Carolina Palmela; Robert Badura; Emília Valadas
Journal:  Germs       Date:  2012-06-01

10.  Characterization of a stress-induced alternate sigma factor, RpoS, of Coxiella burnetii and its expression during the development cycle.

Authors:  R Seshadri; J E Samuel
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.